Varex Imaging Corp has recently filed additional definitive proxy materials, a move that indicates a significant step in its ongoing corporate governance efforts. This filing is crucial as it may affect shareholder engagement and transparency within the company.

Background

Varex Imaging Corp, identified by the CIK number 0001681622, operates under the SIC code 3679, which pertains to Electronic Components, NEC. The company is listed on the Nasdaq under the ticker symbol VREX. Recent filings include a DEFA14A filed on October 22, 2026, and an 8-K filed on the same day.

What the Filing Says

The recent filing, accession number 0001104659-26-117963, provides additional definitive proxy soliciting materials. However, specific details regarding the content of these materials were not disclosed in the filing.

Impact

This filing may influence various stakeholders, including shareholders and potential investors, as it reflects Varex's commitment to corporate governance. The electronic components industry may also take note of Varex's actions as a benchmark for best practices.

What's Next

The filing does not say what happens next.

Company Information

Varex Imaging Corp is incorporated in Delaware and has a fiscal year ending on October 2. The company's Employer Identification Number (EIN) is 813434516. The business address is 1678 S. Pioneer Road, Salt Lake City, UT 84104, with a contact number of 801-972-5000.

Document Details

The filing includes a definitive proxy statement (DEFA14A) and is accessible through the SEC's EDGAR database. The document is identified as accession number 0001104659-26-117963 and was filed on October 22, 2026. The size of the DEFA14A document is 111,605 bytes, and a complete submission text file is also available, with a size of 112,597 bytes.

Filing Context

While the filing indicates a focus on corporate governance, it does not provide specific details about the proposals or changes being solicited from shareholders. Additionally, the filing lacks information regarding any upcoming shareholder meetings or voting procedures related to the proxy materials.